Investigational Drug Information for Clazakizumab
✉ Email this page to a colleague
What is the drug development status for Clazakizumab?
Clazakizumab is an investigational drug.
There have been 16 clinical trials for Clazakizumab.
The most recent clinical trial was a Phase 2 trial, which was initiated on October 14th 2019.
The most common disease conditions in clinical trials are COVID-19, Infection, and Kidney Failure, Chronic. The leading clinical trial sponsors are CSL Behring, Vitaeris INC, and NYU Langone Health.
There are four US patents protecting this investigational drug and thirty-three international patents.
Summary for Clazakizumab
| US Patents | 4 |
| International Patents | 33 |
| US Patent Applications | 0 |
| WIPO Patent Applications | 0 |
| Japanese Patent Applications | 0 |
| Clinical Trial Progress | Phase 2 (2019-10-14) |
| Vendors | 0 |
Recent Clinical Trials for Clazakizumab
| Title | Sponsor | Phase |
|---|---|---|
| Improving Physical Function in Older Adults Using an Anti-inflammation Drug: The RIGHT Study | CSL Behring | Phase 2 |
| Improving Physical Function in Older Adults Using an Anti-inflammation Drug: The RIGHT Study | Anne B. Newman | Phase 2 |
| Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis | CSL Behring | Phase 2/Phase 3 |
Clinical Trial Summary for Clazakizumab
Top disease conditions for Clazakizumab
Top clinical trial sponsors for Clazakizumab
US Patents for Clazakizumab
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Clazakizumab | ⤷ Try a Trial | Soluble C5aR antagonists | ChemoCentryx, Inc. (Mountain View, CA) | ⤷ Try a Trial |
| Clazakizumab | ⤷ Try a Trial | Cholestosome vesicles for incorporation of molecules into chylomicrons | THERASYN SENSORS, INC. (Eggertsville, NY) | ⤷ Try a Trial |
| Clazakizumab | ⤷ Try a Trial | Soluble C5aR antagonists | ChemoCentryx, Inc. (Mountain View, CA) | ⤷ Try a Trial |
| Clazakizumab | ⤷ Try a Trial | Binding-triggered transcriptional switches and methods of use thereof | The Regents of the University of California (Oakland, CA) | ⤷ Try a Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Clazakizumab
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Clazakizumab | Argentina | AR108097 | 2036-04-04 | ⤷ Try a Trial |
| Clazakizumab | Australia | AU2017246228 | 2036-04-04 | ⤷ Try a Trial |
| Clazakizumab | Brazil | BR112018070214 | 2036-04-04 | ⤷ Try a Trial |
| Clazakizumab | Canada | CA3019137 | 2036-04-04 | ⤷ Try a Trial |
| Clazakizumab | Chile | CL2018002803 | 2036-04-04 | ⤷ Try a Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
